ACADIA Pharmaceuticals Inc — 貸借対照表 (NASDAQ:ACAD) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 782.62 M700.12 M587.81 M748.96 M1.19 B1.56 B 負債合計 155.61 M159.23 M187.4 M317.2 M454.96 M336.81 M 純資産合計 627.01 M540.89 M400.41 M431.75 M732.79 M1.23 B 負債および純資産合計 782.62 M700.12 M587.81 M748.96 M1.19 B1.56 B 有利子負債合計 —————— 純負債 ——————

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

ニュース

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

JAZZ or ACAD: Which Is the Better Value Stock Right Now?

Acadia Pharmaceuticals、Jonathan M. Pooleを取締役会に任命

Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

BofAがAcadia Pharmaceuticalsの目標株価を引き下げ、欧州での後退を受けて